Papers

1

Total Citations

3

H-Index

1

About

Kai Yu is an emerging researcher specializing in surgical oncology and evidence-based medicine, with a particular focus on the clinical evaluation of robot-assisted surgical technologies in cancer care. His most notable work, a 2024 systematic review examining the efficacy and safety of robot-assisted surgery (RAS) in cancer patients, represents a significant contribution to the field by synthesizing evidence from randomized controlled trials — a methodologically rigorous approach that addresses a critical gap in the literature. At a time when robotic surgical systems are being adopted at an accelerating pace across oncological disciplines, Yu's research brings much-needed clarity to questions surrounding patient safety and procedural outcomes, helping to ground clinical decision-making in robust empirical evidence. Although his publication record is still developing, with his flagship study already accumulating early citations since its 2024 release, Yu demonstrates a clear commitment to translational research that bridges surgical innovation and patient-centered outcomes. His work is poised to inform surgical guidelines and shape how clinicians weigh the benefits and risks of robotic approaches across diverse cancer populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
The efficacy and safety of robot-assisted surgery in cancer patients: a systematic review of randomized controlled trials
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: China Aerospace Science and Industry Corporation (China)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago